Cargando…

Serum soluble Toll-like receptor 4 and the risk of hepatocellular carcinoma in hepatitis C virus patients

INTRODUCTION: Soluble Toll-like receptor 4 (sTLR4) is a negative regulator of TLR4 signalling that has been reported in different diseases. In this study, we aimed to assess the serum levels of sTLR4 in hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC) and to investigate the correlation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Elkammah, Maha, Gowily, Ahmed, Okda, Tarek, Houssen, Maha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2021
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836282/ https://www.ncbi.nlm.nih.gov/pubmed/33531868 http://dx.doi.org/10.5114/wo.2020.102818

Ejemplares similares

Serum soluble toll-like receptor 2 and 4 as diagnostic and prognostic biomarkers for non-Hodgkin lymphoma
por: Fakhry, Nouran, et al.
Publicado: (2020)

Association between serum soluble Toll-like receptor 2 and 4 and the risk of breast cancer
por: El-Kharashy, Ghada, et al.
Publicado: (2021)

Associations Between Serum Soluble Toll-like Receptors 4 and 9 and Breast Cancer in Egyptian Patients
por: Moaz, Inas, et al.
Publicado: (2023)

Emerging role of Toll-like receptor 4 in hepatocellular carcinoma
por: Yang, Jing, et al.
Publicado: (2015)

The Potential Interplay of Adipokines with Toll-Like Receptors in the Development of Hepatocellular Carcinoma
por: Wang, Shen-Nien, et al.
Publicado: (2011)

Blocking Toll-like receptor 9 attenuates bleomycin-induced pulmonary injury
por: Alzahrani, Badr, et al.
Publicado: (2022)

Soluble Toll-like receptor 4 is a potential serum biomarker in non-small cell lung cancer
por: Wei, Feng, et al.
Publicado: (2016)

Downregulation of toll-like receptor 4 induces suppressive effects on hepatitis B virus-related hepatocellular carcinoma via ERK1/2 signaling
por: Wang, Yiting, et al.
Publicado: (2015)

Toll-like receptor 4: a target for chemoprevention of hepatocellular carcinoma in obesity and steatohepatitis
por: Nguyen, Jennifer, et al.
Publicado: (2018)

Single Nucleotide Polymorphisms of Toll-Like Receptor 7 and Toll-Like Receptor 9 in Hepatitis C Virus Infection Patients from Central China
por: Wei, Xin-su, et al.
Publicado: (2014)

The Synergistic Antitumor Effect of Decitabine and Vorinostat Combination on HepG2 Human Hepatocellular Carcinoma Cell Line via Epigenetic Modulation of Autophagy–Apoptosis Molecular Crosstalk
por: Salama, Basant M., et al.
Publicado: (2023)

The antitumour effect of galangin and luteolin with doxorubicin on chemically induced hepatocellular carcinoma in rats
por: Atwa, Gamal, et al.
Publicado: (2021)

Association of Toll-Like Receptor 3 Single-Nucleotide Polymorphisms and Hepatitis C Virus Infection
por: Al-Anazi, Mashael R., et al.
Publicado: (2017)

Toll-Like Receptors in Hepatic Ischemia/Reperfusion and Transplantation
por: Evankovich, John, et al.
Publicado: (2010)

Toll-like Receptor Response to Hepatitis C Virus Infection: A Recent Overview
por: Kayesh, Mohammad Enamul Hoque, et al.
Publicado: (2022)

Intrahepatic Toll-Like Receptor 3 in Chronic HBV Infection Subjects: Asymptomatic Carriers, Active Chronic Hepatitis, Cirrhosis, and Hepatocellular Carcinoma
por: Yin, Jia Wen, et al.
Publicado: (2016)

The association between Toll-like receptor 2 single-nucleotide polymorphisms and hepatocellular carcinoma susceptibility
por: Junjie, Xie, et al.
Publicado: (2012)

Single Nucleotide Polymorphisms of Toll-Like Receptor 4 Decrease the Risk of Development of Hepatocellular Carcinoma
por: Minmin, Shi, et al.
Publicado: (2011)

Serum levels of soluble Fas, soluble tumor necrosis factor-receptor II, interleukin-2 receptor and interleukin-8 as early predictors of hepatocellular carcinoma in Egyptian patients with hepatitis C virus genotype-4
por: Zekri, Abdel-Rahman N, et al.
Publicado: (2010)

The Association of Toll-Like Receptor 4 Polymorphism with Hepatitis C Virus Infection in Saudi Arabian Patients
por: Al-Qahtani, Ahmed A., et al.
Publicado: (2014)

The Soluble Form of Toll-Like Receptor 2 Is Elevated in Serum of Multiple Sclerosis Patients: A Novel Potential Disease Biomarker
por: Hossain, Md Jakir, et al.
Publicado: (2018)

Soluble Toll-Like Receptor 4 Impairs the Interaction of Shiga Toxin 2a with Human Serum Amyloid P Component
por: Brigotti, Maurizio, et al.
Publicado: (2018)

Insights into Soluble Toll-Like Receptor 2 as a Downregulator of Virally Induced Inflammation
por: Henrick, Bethany M., et al.
Publicado: (2016)

Toll-like receptors and their soluble forms differ in the knee and thumb basal osteoarthritic joints
por: Barreto, Goncalo, et al.
Publicado: (2017)

Analysis of Toll-Like Receptors in Human Milk: Detection of Membrane-Bound and Soluble Forms
por: Cattaneo, Chiara, et al.
Publicado: (2019)

Diagnostic Value of Serum Level of Soluble Tumor Necrosis Factor Receptor IIα in Egyptian Patients With Chronic Hepatitis C Virus Infection and Hepatocellular Carcinoma
por: Fouad, Shawky A, et al.
Publicado: (2014)

Hepatitis C Virus Infection and Intrinsic Disorder in the Signaling Pathways Induced by Toll-Like Receptors
por: Redwan, Elrashdy M., et al.
Publicado: (2022)

Serum vascular endothelial growth factor as a tumor marker for hepatocellular carcinoma in hepatitis C virus-related cirrhotic patients
por: Alzamzamy, Ahmed, et al.
Publicado: (2021)

Single Nucleotide Polymorphisms of Toll-like Receptor 4 in Hepatocellular Carcinoma—A Single-Center Study
por: Androutsakos, Theodoros, et al.
Publicado: (2022)

Toll-like receptors and toll-like receptor-targeted immunotherapy against glioma
por: Xun, Yang, et al.
Publicado: (2021)

The Distinctive Activation of Toll-Like Receptor 4 in Human Samples with Sepsis
por: Thon, Patrick, et al.
Publicado: (2022)

Prognostic impact of toll-like receptors gene polymorphism on outcome of COVID-19 pneumonia: A case-control study
por: Alseoudy, Mahmoud M., et al.
Publicado: (2022)

Soluble toll like receptor 2 (TLR-2) is increased in saliva of children with dental caries
por: Zhao, Alyssa, et al.
Publicado: (2014)

Trypanosoma cruzi and Its Soluble Antigens Induce NET Release by Stimulating Toll-Like Receptors
por: Sousa-Rocha, Daniel, et al.
Publicado: (2015)

Differential profiles of soluble and cellular toll like receptor (TLR)-2 and 4 in chronic periodontitis
por: AlQallaf, Hawra, et al.
Publicado: (2018)

Dual inhibitors of hepatitis C virus and hepatocellular carcinoma: design, synthesis and docking studies
por: El-Miligy, Mostafa MM, et al.
Publicado: (2017)

Anti-viral role of toll like receptor 4 in hepatitis B virus infection: An in vitro study
por: Das, Dipanwita, et al.
Publicado: (2016)

Meta-analysis of the association between toll-like receptor gene polymorphisms and hepatitis C virus infection
por: Du, Yuxuan, et al.
Publicado: (2023)

Toll-like receptor 4 signaling in liver injury and hepatic fibrogenesis
por: Guo, Jinsheng, et al.
Publicado: (2010)

Toll‐like receptor‐2 exacerbates murine acute viral hepatitis
por: Bleau, Christian, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_eh7mghtbbgt4vvc743a93edidc